Treatment of L-DOPA-induced Dyskinesia in Parkinson’s Disease
Repurposed antidepressant agents for treating levodopa-induced dyskinesia in Parkinson's disease
Background:
Dopamine replacement therapy with L-DOPA remains the gold-standard treatment for the crippling movement disruptions affecting >10 million Parkinson’s Disease patients worldwide. However, L-DOPA therapies, especially after...
Published: 12/29/2023
|
Inventor(s): Christopher Bishop
Keywords(s): #SUNYresearch, #SUNYresearch, Technologies, XCEED
Category(s): Campus > Binghamton University, Technology Classifications > Biomedical Science and Engineering, Technology Classifications > Healthcare
|